Studies Will Support Investigational New Drug Application (IND) with the US FDA, Including Design of Phase 2 TrialTORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: ...

An often overlooked risk for patients receiving dialysis for kidney failure or related conditions is infection. Unfortunately, infections among dialysis patients are both common and serious, ...

MILFORD — A biopharmaceutical company with headquarters in Germany expanded its Maple Avenue location with a third production line this month, investing more than $70 million to increase manufacturing ...

Deerfield, Ill.-based Baxter has announced plans to create two separate and independent global healthcare companies. One of the companies will be geared toward the development and marketing of ...

GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced today that Ministry of Food and Drug Safety (MFDS) in South Korea has approved the Investigational New Drug (IND) ...

The use of biologics is rapidly increasing as new drugs are approved for label expansions. Monoclonal antibodies, multispecific antibodies, and antibody-drug conjugates (ADCs) are being implemented in ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...

The biopharmaceutical industry faces strict regulations worldwide, making it essential to meet international standards before any new therapy can enter the market. Staying informed about the current ...

Connect Biopharma Holdings ( ($CNTB) ) has provided an update. On December 17, 2025, Connect Biopharma Holdings announced that Kan Chen, Ph.D., a ...

The biotechnology industry had a good time last year and the market expects the trend to continue in 2013 as well. As the chart below shows, the AMEX biotechnology index has outperformed the S&P 500 ...

A well-defined CAPA system is essential for any biopharmaceutical company to drive quality improvements across the organization. Hence, it is imperative for biopharmaceutical organizations to measure ...